We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
does this make it clearer? i asked chatgpt4 to analyse the rns and set out the consequences. with an appropriate disclaimer, this is what it replied (though nicely formatted for ease of reading)
"chatgpt
based on the provided announcement about the 2023 long-term incentive plan (ltip) grant for tissue regenix, here's a summary of the consequences structured in sub-headings and bullet points:
*grant of restricted share units (rsus)*
recipients: daniel lee (ceo) and david ****e (cfo).
*quantity of rsus*:
daniel lee was initially awarded 19,807,390 rsus, reduced to 198,073 rsus post-share consolidation.
david ****e was initially awarded 15,367,803 rsus, reduced to 153,678 rsus post-share consolidation.
*effective date*: granted on 21 march 2023.
*conditions and exercise price*
exercise price: initially 0.1p per ordinary share, adjusted to 10p after share consolidation.
vesting conditions:
tied to continued service for three years.
satisfaction of performance conditions related to total shareholder return, annual revenue and profitability targets,
and personal performance metrics.
*performance metrics*: detailed metrics will be disclosed in the company's 2023 annual report.
*impact on share capital*
*post-grant holdings*:
daniel lee holds options over a total of 756,897 rsus.
david ****e holds options over a total of 514,002 rsus.
*percentage of issued share capital*:
daniel lee's holdings represent 1.1% of current issued share capital.
david ****e's holdings represent 0.7% of current issued share capital.
*implications for stakeholders*
incentivization of executives: aligns the interests of the ceo and cfo with long-term company performance and
shareholder value.
potential for share dilution: issuance of new shares upon rsu vesting could dilute existing shareholders' equity.
performance-linked rewards: encourages executives to meet specific financial and operational targets.
*market perception*
investor confidence: could be seen as a vote of confidence in the executives' ability to drive company growth.
transparency: detailed performance conditions in the annual report might enhance transparency for investors.
these points provide a broad overview of the announcement's implications. the actual impact might vary depending on the company's performance and market conditions."
as ever dyor
No way is this rise justified from the small volume of trading we see, and I don't believe it is traded elsewhere. Traders must be reacting to a leak - or an unfounded rumour. Anyway - here's hoping!
Me too - even bought a few more this morning
I have continued to hold because Richard Sneller bought in. He has a good track record.
I would not give any credit to my own speculations. On facts though, we are under valued by a factor of 70%, and should be trading in the 90p to 110p range. So this move is long overdue. Maybe this update will remove any remaining doubts about valuations, and it will naturally go this range.
I am invested here from 2020, waiting patiently, happy to wait another 18 months or so, when we should be 3 to 4 times of current price, not that keen to just take 100% of profit. Having said that if majority of the holders are happy with this there is nothing one can do. Also, growth needs funding, which leads to dilutions, so if an offer at the right level comes, why not!
If my memory serves me correctly it wouldn't be the first time this share has done well in January then dropped again for most of the year.
Surely we deserve a steady increase now?
Somethings afoot , haven't seen this past 57p for a looooooong time.
Mental.. Loosing the plot
Be careful of your head. The speed that this move can cause metal health issues. Strange time to release rns last night. May be they need to clear the decks for action and a BOOM
I have been cracking my head from last night... expected an RNS this morning which didn't come... even the wording is not clear.. if I get it right, they were already vested these shares last year and we are not been told until now, which is bad, but I think it is more than that...may be a TO deal is in workings, and they are getting their ducks in the row.. I don't know.... all speculations
What was the point of that rns?
Box ticking?
I think last nights RNS told us what’s coming today!
Revenue FY 31 million, net income breakeven. And they may update on distribution deals.
Thought I once owned them .
Primary bid 21/5/20 @ 25p
Sold half of them 23/11/20 @ 45p
Half again 25/11/20 @ 48p.
The rest 5/2/21 @ 74.9p
Yep - with reg approvals in the pipeline, great products and management, distribution agreements only a matter of time in my opinion
I do not think I could take the stress of a massively positive rns. I have held these for so long I have forgotten why I bought them. Anything over a 10% rise would cause me palpitations. I shall go into recovery mode next week when the T/U pops up...
A few decent buys this morning. Nice to see.
Nice buy there are we due for a maiden profit ,and news leaking.
Too right - next to no - actually no sp improvement over similar period I have had them
Can’t think there will be any negative surprises as we would have heard something by now - my best guess is modest growth but hope I am pleasantly surprised ! Should be any time now until end of month
No negative surprises. If there are, the SP will tank.
Usually one in late January right? And we're expecting it to be positive...?
I have been invested here for over two years and I am more or less still where I was when I bought them. Problem is I know if I sell them it will probably go BOOM
Excellent post, thank you
TA due any day. Would imagine will show continued progress but nothing out of the ordinary otherwise the SP surely would have increased over the last few months
At some point in next few years in my opinion when reg approvals are in and with distribution agreements largely set up this is going to fly. I do not understand why at this low sp we have not been taken over
Think are management are first class
I’ve been reading recently about decellularised tissue scaffolds in regenerative medicine. Think tissue regenix is on the right path, particularly as the elderly population grows.
Probably need to get out more 😜
https://www.nature.com/articles/s41536-023-00312-4
https://www.nature.com/articles/srep13079
V sound observation
Why are you known as Jolly Speculator. I feel like going off and topping myself now Lol